This report provides a picture of the risks and challenges posed by this convergence. It analyses the extent to which concerns arising from new technological developments can be dealt with through existing governance mechanisms.
The World Health Organization (WHO) developed the Global Influenza Strategy for 2019–2030 to enhance global and national pandemic preparedness, to combat the ongoing threat of zoonotic influenza, and to improve seasonal influenza prevention and control in all countries.
This guide provides principles, best practices, and options to assist countries in achieving sustainable and functional collaboration at the human-animal-environment interface.
The purpose of this guidance document is to provide feed and ingredient manufacturers with recommendations that may be used to develop a biosecurity plan to control the potential spread of animal diseases through feed and feed ingredients.
This review examines evidence from the history of variolation, data on mucosal infection collected in the last decades of smallpox transmission, aerosol measurements, animal models, reports of smallpox lung among healthcare workers, and the epidemiology of smallpox regarding the potential importance of fine particle aerosol mediated transmission.
This paper summarizes clinical syndromes and possible treatment options, for both developed and low-resource settings, and offer performance indicators and clinical metrics for case management.
This report provides recommendations issued by the US Centers for Disease Control and Prevention (CDC) for Q fever recognition, clinical and laboratory diagnosis, treatment, management, and reporting for health-care personnel and public health professionals. The guidelines address treatment of acute and chronic phases of Q fever illness in children, adults, and pregnant women, as well as management of occupational exposures.
This paper offers an analytical framework is used to assess the risks and benefits of such dual use research, and relevant components of biosecurity policy and the biodefense enterprise (including the acquisition of medical countermeasures) in the United States are discussed.
This toolkit helps you work with key stakeholders to develop methods for the dispensing of medical countermeasures (such as antibiotics, antivirals, vaccines, and supplies) during public health emergencies involving public health agencies, hospitals, long term care facilities, and pharmacies.
This document presents a set of recommended standards for mass antibiotic dispensing that focus on the “points of dispensing” (or PODs, locations where the members of the public would go to receive life-saving antibiotics or other medical countermeasures during a large-scale public health emergency). Specifically, the standards address (1) the number and location of PODs, (2) internal POD operations, (3) POD staffing, and (4) POD security.